Patent 7151182 was granted and assigned to Basilea Pharmaceutica on December, 2006 by the United States Patent and Trademark Office.
N-substituted carbamoyloxyalkyl-azolium derivatives which have antifungal activity and are useful for the treatment of fungal diseases.